{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T14:34:26Z","timestamp":1778337266045,"version":"3.51.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/bf03262472","type":"journal-article","created":{"date-parts":[[2012,12,29]],"date-time":"2012-12-29T20:15:15Z","timestamp":1356812115000},"page":"375-389","source":"Crossref","is-referenced-by-count":6,"title":["Olmesartan Medoxomil-Based Antihypertensive Therapy Evaluated by Ambulatory Blood Pressure Monitoring"],"prefix":"10.1007","volume":"12","author":[{"given":"Steven G.","family":"Chrysant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Wilford","family":"Germino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel M.","family":"Neutel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,29]]},"reference":[{"issue":"21","key":"2472_CR1","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIRCULATIONAHA.107.183885","volume":"115","author":"C Rosendorff","year":"2007","unstructured":"Rosendorff C, Black HR, Cannon CP, et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 2007 May 29; 115(21): 2761\u201388","journal-title":"Circulation"},{"issue":"18","key":"2472_CR2","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa003417","volume":"345","author":"RS Vasan","year":"2001","unstructured":"Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001 Nov 1; 345(18): 1291\u20137","journal-title":"N Engl J Med"},{"issue":"9349","key":"2472_CR3","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","volume":"360","author":"S Lewington","year":"2002","unstructured":"Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002 Dec 14; 360(9349): 1903\u201313","journal-title":"Lancet"},{"issue":"9455","key":"2472_CR4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)70151-3","volume":"365","author":"PM Kearney","year":"2005","unstructured":"Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005 Jan 15\u201321; 365(9455): 217\u201323","journal-title":"Lancet"},{"issue":"20","key":"2472_CR5","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.2010.650","volume":"303","author":"BM Egan","year":"2010","unstructured":"Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988\u20132008. JAMA 2010 May 26; 303(20): 2043\u201350","journal-title":"JAMA"},{"issue":"19","key":"2472_CR6","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003 May 21; 289(19): 2560\u201372","journal-title":"JAMA"},{"issue":"9","key":"2472_CR7","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1097\/HJH.0b013e3282f0580f","volume":"25","author":"G Mancia","year":"2007","unstructured":"Mancia G, De Backer G, Dominiczak A, et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007 Sep; 25(9): 1751\u201362","journal-title":"J Hypertens"},{"issue":"11","key":"2472_CR8","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1097\/HJH.0b013e328333146d","volume":"27","author":"G Mancia","year":"2009","unstructured":"Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009 Nov; 27(11): 2121\u201358","journal-title":"J Hypertens"},{"issue":"Suppl1","key":"2472_CR9","first-page":"S11","volume":"35","author":"American Diabetes Association","year":"2012","unstructured":"American Diabetes Association. Standards of medical care in diabetes \u2014 2012. Diabetes Care 2012 Jan; 35 Suppl 1: S11\u201363","journal-title":"Diabetes Care"},{"issue":"Suppl2","key":"2472_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.17.S2.1","volume":"17","author":"Y Handelsman","year":"2011","unstructured":"Handelsman Y, Mechanick JI, Blonde L, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract 2011 Mar\u2013Apr; 17 Suppl 2: 1\u201353","journal-title":"Endocr Pract"},{"issue":"5","key":"2472_CR11","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/HYPERTENSIONAHA.110.152892","volume":"56","author":"JM Flack","year":"2010","unstructured":"Flack JM, Sica DA, Bakris G, et al. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension 2010 Nov; 56(5): 780\u2013800","journal-title":"Hypertension"},{"issue":"5","key":"2472_CR12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/archinte.163.5.525","volume":"163","author":"JG Douglas","year":"2003","unstructured":"Douglas JG, Bakris GL, Epstein M, et al. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 2003 Mar 10; 163(5): 525\u201341","journal-title":"Arch Intern Med"},{"issue":"1","key":"2472_CR13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2337\/diacare.25.1.134","volume":"25","author":"C Arauz-Pacheco","year":"2002","unstructured":"Arauz-Pacheco C, Parrott MA, Raskin P. The treatment of hypertension in adult patients with diabetes. Diabetes Care 2002 Jan; 25(1): 134\u201347","journal-title":"Diabetes Care"},{"issue":"1","key":"2472_CR14","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/01.hjh.0000271504.62325.a4","volume":"25","author":"AC Pessina","year":"2007","unstructured":"Pessina AC. Target organs of individuals with diabetes caught between arterial stiffness and damage to the microcirculation. J Hypertens Suppl 2007 Jun; 25(1): S13\u20138","journal-title":"J Hypertens Suppl"},{"issue":"Suppl1","key":"2472_CR15","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc09-S013","volume":"32","author":"American Diabetes Association","year":"2009","unstructured":"American Diabetes Association. Standards of medical care in diabetes \u2014 2009. Diabetes Care 2009 Jan; 32 Suppl 1: S13\u201361","journal-title":"Diabetes Care"},{"issue":"3","key":"2472_CR16","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1161\/CIRCULATIONAHA.108.191261","volume":"119","author":"D Lloyd-Jones","year":"2009","unstructured":"Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics \u2014 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009 Jan 27; 119(3): e21\u2013181","journal-title":"Circulation"},{"issue":"4","key":"2472_CR17","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1161\/CIRCULATIONAHA.107.187998","volume":"117","author":"W Rosamond","year":"2008","unstructured":"Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics \u2014 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008 Jan 29; 117(4): e25\u2013146","journal-title":"Circulation"},{"key":"2472_CR18","unstructured":"National Institute for Health and Clinical Excellence. Hypertension: the clinical management of primary hypertension in adults. Clinical Guideline 127, Methods, evidence, and recommendations, August 2011: National Institute for Health and Clinical Excellence (NICE); 2011 [online]. Available from http:\/\/www.nice.org.uk\/nicemedia\/live\/13561\/56007\/56007.pdf [Accessed 2011 Dec 14]"},{"issue":"3","key":"2472_CR19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jash.2008.04.002","volume":"2","author":"TG Pickering","year":"2008","unstructured":"Pickering TG, White WB. ASH position paper: when and how to use self (home) and ambulatory blood pressure monitoring. J Am Soc Hypertens 2008 May\u2013Jun; 2(3): 119\u201324","journal-title":"J Am Soc Hypertens"},{"issue":"Suppl.H","key":"2472_CR20","first-page":"35H","volume":"11","author":"ED Frohlich","year":"1995","unstructured":"Frohlich ED. Blood pressure measurement. Can J Cardiol 1995 Nov; 11 Suppl. H: 35H\u20137H","journal-title":"Can J Cardiol"},{"issue":"24","key":"2472_CR21","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa022273","volume":"348","author":"DL Clement","year":"2003","unstructured":"Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003 Jun 12; 348(24): 2407\u201315","journal-title":"N Engl J Med"},{"issue":"5","key":"2472_CR22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/01.CIR.0000154900.76284.F6","volume":"111","author":"TG Pickering","year":"2005","unstructured":"Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans. A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 2005 Feb 8; 111(5): 697\u2013716","journal-title":"Circulation"},{"issue":"3","key":"2472_CR23","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.HYP.35.3.844","volume":"35","author":"P Verdecchia","year":"2000","unstructured":"Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension 2000 Mar; 35(3): 844\u201351","journal-title":"Hypertension"},{"issue":"2","key":"2472_CR24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/ageing\/afm193","volume":"37","author":"ML Burr","year":"2008","unstructured":"Burr ML, Dolan E, O\u2019Brien EW, et al. The value of ambulatory blood pressure in older adults: the Dublin outcome study. Age Ageing 2008 Mar; 37(2): 201\u20136","journal-title":"Age Ageing"},{"issue":"2","key":"2472_CR25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00126097-200104000-00001","volume":"6","author":"WB White","year":"2001","unstructured":"White WB. Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate. Blood Press Monit 2001 Apr; 6(2): 63\u201372","journal-title":"Blood Press Monit"},{"issue":"6","key":"2472_CR26","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/00004872-200406000-00011","volume":"22","author":"P Gosse","year":"2004","unstructured":"Gosse P, Lasserre R, Minifie C, et al. Blood pressure surge on rising. J Hypertens 2004 Jun; 22(6): 1113\u20138","journal-title":"J Hypertens"},{"issue":"4","key":"2472_CR27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/01.CIR.79.4.733","volume":"79","author":"JE Muller","year":"1989","unstructured":"Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989 Apr; 79(4): 733\u201343","journal-title":"Circulation"},{"issue":"5","key":"2472_CR28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00041552-200109000-00010","volume":"10","author":"TG Pickering","year":"2001","unstructured":"Pickering TG, Kario K. Nocturnal non-dipping: what does it augur? Curr Opin Nephrol Hypertens 2001 Sep; 10(5): 611\u20136","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"2472_CR29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejcnurse.2006.05.001","volume":"6","author":"F Routledge","year":"2007","unstructured":"Routledge F, McFetridge-Durdle J. Nondipping blood pressure patterns among individuals with essential hypertension: a review of the literature. Eur J Cardiovasc Nurs 2007 Mar; 6(1): 9\u201326","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"4","key":"2472_CR30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/01.hjh.0000163132.84890.c4","volume":"23","author":"E O\u2019Brien","year":"2005","unstructured":"O\u2019Brien E, Asmar R, Beilin L, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005 Apr; 23(4): 697\u2013701","journal-title":"J Hypertens"},{"issue":"22","key":"2472_CR31","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1056\/NEJMra060433","volume":"354","author":"TG Pickering","year":"2006","unstructured":"Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med 2006 Jun 1; 354(22): 2368\u201374","journal-title":"N Engl J Med"},{"issue":"9798","key":"2472_CR32","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(11)61184-7","volume":"378","author":"K Lovibond","year":"2011","unstructured":"Lovibond K, Jowett S, Barton P, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet 2011 Oct 1; 378(9798): 1219\u201330","journal-title":"Lancet"},{"issue":"1","key":"2472_CR33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00129784-200505010-00003","volume":"5","author":"SE Kjeldsen","year":"2005","unstructured":"Kjeldsen SE, Os I, Hoieggen A, et al. Fixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazide. Am J Cardiovasc Drugs 2005; 5(1): 17\u201322","journal-title":"Am J Cardiovasc Drugs"},{"issue":"2","key":"2472_CR34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jash.2011.09.003","volume":"6","author":"SG Chrysant","year":"2012","unstructured":"Chrysant SG, Izzo JL Jr, Kereiakes DJ, et al. Efficacy and safety of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in study participants with hypertension and diabetes: a sub-population analysis of the TRINITY study. J Am Soc Hypertens 2012 Mar\u2013Apr; 6(2): 132\u201341","journal-title":"J Am Soc Hypertens"},{"issue":"8","key":"2472_CR35","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1751-7176.2009.00147.x","volume":"11","author":"DJ Kereiakes","year":"2009","unstructured":"Kereiakes DJ, Neutel J, Stoakes KA, et al. The effects of an olmesartan medoxomil-based treatment algorithm on 24-hour blood pressure levels in elderly patients aged 65 and older. J Clin Hypertens (Greenwich) 2009 Aug; 11(8): 411\u201321","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"3","key":"2472_CR36","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1185\/03007990903553556","volume":"26","author":"JM Neutel","year":"2010","unstructured":"Neutel JM, Kereiakes DJ, Waverczak WF, et al. Effects of an olmesartan medoxomil based treatment algorithm on 24-hour blood pressure control in patients with hypertension and type 2 diabetes. Curr Med Res Opin 2010 Mar; 26(3): 721\u20138","journal-title":"Curr Med Res Opin"},{"issue":"9","key":"2472_CR37","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2165\/11536710-000000000-00000","volume":"30","author":"R Fogari","year":"2010","unstructured":"Fogari R, Taddei S, Holm-Bentzen M, et al. Efficacy and safety of olmesartan medoxomil 40 mg\/hydrochlorothiazide 12.5mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III study. Clin Drug Investig 2010; 30(9): 581\u201397","journal-title":"Clin Drug Investig"},{"issue":"1","key":"2472_CR38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1524-6175X.2007.5713.x","volume":"9","author":"JL Izzo Jr","year":"2007","unstructured":"Izzo Jr JL, Neutel JM, Silfani T, et al. Efficacy and safety of treating stage 2 systolic hypertension with olmesartan and olmesartan\/HCTZ: results of an open-label titration study. J Clin Hypertens (Greenwich) 2007 Jan; 9(1): 36\u201344","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"1","key":"2472_CR39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1751-7176.2009.00217.x","volume":"12","author":"S Oparil","year":"2010","unstructured":"Oparil S, Pimenta E. Efficacy of an olmesartan medoxomil-based treatment algorithm in patients stratified by age, race, or sex. J Clin Hypertens (Greenwich) 2010 Jan; 12(1): 3\u201313","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"3","key":"2472_CR40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1751-7176.2011.00588.x","volume":"14","author":"DJ Kereiakes","year":"2012","unstructured":"Kereiakes DJ, Chrysant SG, Izzo Jr JL, et al. Long-term efficacy and safety of triple-combination therapy with olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide for hypertension. J Clin Hypertens 2012 Mar; 14(3): 149\u201357","journal-title":"J Clin Hypertens"},{"issue":"1","key":"2472_CR41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1291\/hypres.31.7","volume":"31","author":"S Nakayama","year":"2008","unstructured":"Nakayama S, Watada H, Mita T, et al. Comparison of effects of olmesartan and telmisartan on blood pressure and metabolic parameters in Japanese early-stage type-2 diabetics with hypertension. Hypertens Res 2008 Jan; 31(1): 7\u201313","journal-title":"Hypertens Res"},{"issue":"3","key":"2472_CR42","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/HYPERTENSIONAHA.110.163402","volume":"57","author":"WB White","year":"2011","unstructured":"White WB, Weber MA, Sica D, et al. Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension. Hypertension 2011 Mar; 57(3): 413\u201320","journal-title":"Hypertension"},{"issue":"4","key":"2472_CR43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1753944710374745","volume":"4","author":"H Punzi","year":"2010","unstructured":"Punzi H, Neutel JM, Kereiakes DJ, et al. Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study. Ther Adv Cardiovasc Dis 2010 Aug; 4(4): 209\u201321","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"6","key":"2472_CR44","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1751-7176.2010.00422.x","volume":"13","author":"H Punzi","year":"2011","unstructured":"Punzi H, Shojaee A, Waverczak WF, et al. Efficacy of amlodipine and olmesartan medoxomil in hypertensive patients with diabetes and obesity. J Clin Hypertens (Greenwich) 2011 Jun; 13(6): 422\u201330","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"6","key":"2472_CR45","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1751-7176.2011.00437.x","volume":"13","author":"MR Weir","year":"2011","unstructured":"Weir MR, Hsueh WA, Nesbitt SD, et al. A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil +\/\u2212 hydrochlorothiazide. J Clin Hypertens (Greenwich) 2011 Jun; 13(6): 404\u201312","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2472_CR46","unstructured":"Hsueh WA, Shojaee A, Maa J-F, et al. Efficacy of amlodipine\/olmesartan medoxomil \u00b1 HCTZ in obese patients uncontrolled on antihypertensive monotherapy. Curr Med Res Opin. Epub. DOI: 10.1185\/03007995. 2012.740632"},{"issue":"6","key":"2472_CR47","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/11589460-000000000-00000","volume":"28","author":"J Neutel","year":"2011","unstructured":"Neutel J, Kereiakes DJ, Stoakes KA, et al. Blood pressure-lowering efficacy of an olmesartan medoxomil\/hydrochlorothiazide-based treatment algorithm in elderly patients (age >\/=65 years) stratified by age, sex and race: subgroup analysis of a 12-week, open-label, single-arm, dose-titration study. Drugs Aging 2011 Jun 1; 28(6): 477\u201390","journal-title":"Drugs Aging"},{"issue":"5","key":"2472_CR48","first-page":"325","volume":"12","author":"FW Germino","year":"2012","unstructured":"Germino FW, Neutel JM, Dubiel R, et al. Efficacy of olmesartan medoxomil and hydrochlorothiazide fixed-dose combination therapy in patients aged 65 years and older with stage 1 and 2 hypertension or isolated systolic hypertension. Am J Cardiovasc Drugs 2012 Oct; 12(5): 325\u201333","journal-title":"Am J Cardiovasc Drugs"},{"issue":"5","key":"2472_CR49","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/1753944710378675","volume":"4","author":"DJ Kereiakes","year":"2010","unstructured":"Kereiakes DJ, Neutel J. Efficacy of an olmesartan medoxomil-based treatment algorithm in patients with hypertension and type 2 diabetes: analysis of diurnal blood pressure control as assessed by 24-hour ambulatory blood pressure monitoring. Ther Adv Cardiovasc Dis 2010 Oct; 4(5): 285\u201393","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"5","key":"2472_CR50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2165\/11584690-000000000-00000","volume":"10","author":"JM Neutel","year":"2010","unstructured":"Neutel JM, Kereiakes DJ. An olmesartan medoxomil-based treatment algorithm is effective in achieving 24-hour BP control in patients with type 2 diabetes mellitus, regardless of age, race, sex, or severity of hypertension: subgroup analysis of the BENIFICIARY study. Am J Cardiovasc Drugs 2010; 10(5): 289\u2013303","journal-title":"Am J Cardiovasc Drugs"},{"issue":"9","key":"2472_CR51","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.amjcard.2010.12.045","volume":"107","author":"CV Ram","year":"2011","unstructured":"Ram CV, Sachson R, Littlejohn T, et al. Management of hypertension in patients with diabetes using an amlodipine-, olmesartan medoxomil-, and hydrochlorothiazide-based titration regimen. Am J Cardiol 2011 May 1; 107(9): 1346\u201352","journal-title":"Am J Cardiol"},{"issue":"8","key":"2472_CR52","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1751-7176.2009.00152.x","volume":"11","author":"S Tof\u00e9 Povedano","year":"2009","unstructured":"Tof\u00e9 Povedano S, Garcia De La Villa B. 24-hour and nighttime blood pressures in type 2 diabetic hypertensive patients following morning or evening administration of olmesartan. J Clin Hypertens (Greenwich) 2009 Aug; 11(8): 426\u201331","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"6","key":"2472_CR53","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00044011-200929060-00002","volume":"29","author":"M Volpe","year":"2009","unstructured":"Volpe M, Miele C, Haag U. Efficacy and safety of a stepped-care regimen using olmesartan medoxomil, amlodipine and hydrochlorothiazide in patients with moderate-to-severe hypertension: an open-label, long-term study. Clin Drug Investig 2009; 29(6): 381\u201391","journal-title":"Clin Drug Investig"},{"issue":"9","key":"2472_CR54","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1751-7176.2009.00159.x","volume":"11","author":"SG Chrysant","year":"2009","unstructured":"Chrysant SG, Oparil S, Melino M, et al. Efficacy and safety of long-term treatment with the combination of amlodipine besylate and olmesartan medoxomil in patients with hypertension. J Clin Hypertens (Greenwich) 2009 Sep; 11(9): 475\u201382","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"6","key":"2472_CR55","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1291\/hypres.24.641","volume":"24","author":"S Ichikawa","year":"2001","unstructured":"Ichikawa S, Takayama Y. Long-term effects of olmesartan, an Ang II receptor antagonist, on blood pressure and the renin-angiotensin-aldosterone system in hypertensive patients. Hypertens Res 2001 Nov; 24(6): 641\u20136","journal-title":"Hypertens Res"},{"issue":"12","key":"2472_CR56","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/jhh.2010.16","volume":"24","author":"S Oparil","year":"2010","unstructured":"Oparil S, Chrysant SG, Melino M, et al. Long-term efficacy of a combination of amlodipine and olmesartan medoxomil +\/\u2212 hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial. J Hum Hypertens 2010 Dec; 24(12): 831\u20138","journal-title":"J Hum Hypertens"},{"key":"2472_CR57","unstructured":"Kereiakes DJ, Izzo J, Chrysant S, et al. The long-term safety and tolerability of combination olmesartan medoxomil\/amlodipine besylate+hydrochlorothiazide in patients with hypertension: the TRINITY study [abstract]. 23rd Scientific Meeting of the International Society of Hypertension (ISH); 26 Sep 2010; Vancouver; 2010; A1994"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03262472.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03262472\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03262472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T18:17:28Z","timestamp":1562523448000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03262472"}},"subtitle":["Efficacy in High-Risk Patient Subgroups"],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2472"],"URL":"https:\/\/doi.org\/10.1007\/bf03262472","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}